About OZOP Surgical Corp.

The Next Generation in Minimally Invasion Spine Surgery

The OZOP Surgical Story

Ozop Surgical Corp. (OTCQB:OZSC), invents, designs, develops, manufactures, and distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies focused on spine, neurological, and pain management procedures and specialties. Our mission is to economically disrupt the orthopedic and neurosurgical markets by providing premium quality surgical devices that result in immediate significant savings for providers, payors, and patients; and to continue to design and manufacture cutting-edge surgical solutions, with an emphasis on our innovations in the rapidly growing field of minimally invasive surgery.

The Company controls an IP portfolio of innovative products and technologies that it is beginning to successfully commercialize. Products in the pipeline include visualization tools for MIS, such as light filtration that presents a better anatomical view of the surgical field in real time, and 3D technology that offers improved depth perception, better visualization of anatomic details, and improved overall surgical performance. Also in development is a revolutionary orthopedic device and procedure, the first truly MIS interbody device and fusion procedure.

OZOP Surgical Executive Management Team

Brian Conway,  CEO

BIO COMING SOON

Michael Chermak,  Director

Michael Chermak has over 30 years of experience in healthcare-related ventures. Previously, he was the founder and CEO of Healthdemographics, Inc., a company in the healthcare predictive data and decision support business. Healthdemographics had over 1,200 clients worldwide and was regularly cited by the Wall Street Journal in articles about the healthcare industry. He sold the company in 1997 to Medirisk.

In 1998, he was the co-founder, initial investor, and original Chairman of Medibuy.com, an Internet healthcare supply vendor. Medibuy raised over $140 million in its first 18 months of operation backed by leading VCs such as Kleiner Perkins, Sequoia, Oak, and institutional investors including Alianz. Medibuy acquired the ecommerce initiatives of two leading GPOs, Premier and Columbia HCA, that at one time accounted for nearly 70% of healthcare product expenditures in the US. Medibuy was sold to GHX (Global Health Exchange), an ecommerce company founded by General Electric, Abbot, Baxter, Medtronic. Becton-Dickinson, Braun, Guidant, Tyco, Siemens, and others.

He worked in China for over 6 years and was the former Chairman and CEO of Bridgetech Holdings International (OTC: BGTH), which focused on introducing Western medicine into China. He has served on the Board of Directors and as an Audit Committee member of Beijing Origin Seed (NASDAQ: SEED).

Michael graduated from the University of New Mexico, Anderson School of Management. Michael and his wife fund and run a 501(c)(3) focused on animal rescue and the support of rescue organizations.

For distributor inquiries, please email:
distributor@ozopsurgical.com

If you have products that you would like us to distribute:
product@ozopsurgical.com

For all other inquiries:
info@ozopsurgical.com

866-286-1055

About

Products

Investors

Terms of Use

Privacy Policy

© 2018 OZOP Surgical Corp. | All Worldwide Rights Reserved | Site design by Batch Creative